Literature DB >> 24505931

[Normal values of retinal sensitivity determined by macular integrity assessment].

Atsushi Fujiwara1, Chieko Shiragami2, Saki Manabe2, Saeko Izumibata2, Akiko Murata2, Fumio Shiraga3.   

Abstract

PURPOSE: To investigate the macular sensitivity of healthy eyes of a wide age range as determined by macular Integrity Assessment (MAIA), and to investigate factors affecting macular sensitivity. SUBJECTS AND METHODS: A total of 120 eyes of 120 healthy volunteers with a best-corrected visual acuity of 20/20 or better, and of a mean age of 43.1 years. Macular sensitivity was examined by a standard grid, a 37-stimuli grid covering the central 10 degrees of the retina including one centering point.
RESULTS: The central sensitivity (CS) was 28.9 dB for subjects under 20 years, 27.2 dB for subjects between 20 to 60 years, and 24.5 dB for subjects over 60 years. The average sensitivity (AS) was 29.6 dB for subjects under 20 years, and after that the sensitivity was 28.7 dB and 26.3 dB. Both CS and AS in subjects over 60 years exhibited a significantly lower sensitivity than in subjects under the age of 20 (p = 0.01). Regression analysis results indicated that the sensitivity gradually decreased by approximately 0.6 dB every 10 years (p = 0.01). The age and development of axial length were statistically significant factors influencing the decline in sensitivity (p = 0.01). When each stimulus position was investigated, the center (0 degrees) was significantly lower (26.4 dB) than surrounding stimulus positions (1 degree: 28.9 dB, 3 degrees: 28.7 dB, 5 degrees: 27.8 dB) (p = 0.01).
CONCLUSION: The macular sensitivity in healthy Japanese subjects calculated by MAIA exhibited a significantly low value with aging, and sensitivity decreased with the advance in the development of axial length. The sensitivity of surrounding stimulus positions was higher than in the center (0 degrees).

Entities:  

Mesh:

Year:  2014        PMID: 24505931

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  6 in total

1.  Artificial Intelligence for the Estimation of Visual Acuity Using Multi-Source Anterior Segment Optical Coherence Tomographic Images in Senile Cataract.

Authors:  Hyunmin Ahn; Ikhyun Jun; Kyoung Yul Seo; Eung Kweon Kim; Tae-Im Kim
Journal:  Front Med (Lausanne)       Date:  2022-05-17

2.  Different fixation targets affect retinal sensitivity obtained by microperimetry in normal individuals.

Authors:  Tomohiro Nizawa; Takayuki Baba; Masayasu Kitahashi; Toshiyuki Oshitari; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2017-11-14

3.  Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.

Authors:  Alfredo Niro; Giancarlo Sborgia; Alessandra Sborgia; Luigi Sborgia; Claudio Furino; Nicola Recchimurzo; Giovanni Alessio
Journal:  J Ophthalmol       Date:  2018-09-09       Impact factor: 1.909

4.  Inverted internal limiting membrane-flap technique for large macular hole: a microperimetric study.

Authors:  Giancarlo Sborgia; Alfredo Niro; Alessandra Sborgia; Valeria Albano; Tiziana Tritto; Luigi Sborgia; Valentina Pastore; Rossella Donghia; Ermete Giancipoli; Nicola Recchimurzo; Francesco Boscia; Giovanni Alessio
Journal:  Int J Retina Vitreous       Date:  2019-10-18

5.  Retinal Differential Light Sensitivity Variation Across the Macula in Healthy Subjects: Importance of Cone Separation and Loci Eccentricity.

Authors:  Danuta M Sampson; Danial Roshandel; Avenell L Chew; Yufei Wang; Paul G Stevenson; Matthew N Cooper; Elaine Ong; Lawrence Wong; Jonathan La; David Alonso-Caneiro; Enid Chelva; Jane C Khan; David D Sampson; Fred K Chen
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

6.  Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion.

Authors:  Masahiko Sugimoto; Atsushi Ichio; Mineo Kondo
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.